Cargando…

Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?

Detalles Bibliográficos
Autores principales:	Ziegler, Laura, Klemis, Verena, Schmidt, Tina, Schneitler, Sophie, Baum, Christina, Neumann, Jürgen, Becker, Sören L., Gärtner, Barbara C., Sester, Urban, Sester, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628342/ http://dx.doi.org/10.1016/j.ebiom.2023.104853

Ejemplares similares

Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination
por: Ziegler, Laura, et al.
Publicado: (2023)

Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients
por: Schmidt, Tina, et al.
Publicado: (2021)

High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
por: Schub, David, et al.
Publicado: (2020)

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
por: Schmidt, Tina, et al.
Publicado: (2021)

Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens
por: Klemis, Verena, et al.
Publicado: (2022)

Transient Positive SARS-CoV-2 PCR without Induction of Systemic Immune Responses
por: Gärtner, Barbara C., et al.
Publicado: (2023)

NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens
por: Hielscher, Franziska, et al.
Publicado: (2022)

VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs
por: Schub, David, et al.
Publicado: (2018)

Levels of CMV Specific CD4 T Cells Are Dynamic and Correlate with CMV Viremia after Allogeneic Stem Cell Transplantation
por: Widmann, Thomas, et al.
Publicado: (2008)

Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022)

Pooling of samples for testing for SARS-CoV-2 in asymptomatic people
por: Lohse, Stefan, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing – Authors' reply
por: Lohse, Stefan, et al.
Publicado: (2020)

Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin
por: Mohammad, Leyla, et al.
Publicado: (2023)

A Polyclonal Immune Function Assay Allows Dose-Dependent Characterization of Immunosuppressive Drug Effects but Has Limited Clinical Utility for Predicting Infection on an Individual Basis
por: Marx, Stefanie, et al.
Publicado: (2020)

Antigen-Specific CD4 T Cells Are Induced after Intravesical BCG-Instillation Therapy in Patients with Bladder Cancer and Show Similar Cytokine Profiles as in Active Tuberculosis
por: Elsäßer, Julia, et al.
Publicado: (2013)

Whole-Blood Flow-Cytometric Analysis of Antigen-Specific CD4 T-Cell Cytokine Profiles Distinguishes Active Tuberculosis from Non-Active States
por: Sester, Urban, et al.
Publicado: (2011)

A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial
por: Ahlenstiel-Grunow, Thurid, et al.
Publicado: (2014)

Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients
por: Leyking, Sarah, et al.
Publicado: (2015)

Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
por: Wilkens, Heinrike, et al.
Publicado: (2016)

Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients
por: Egli, Adrian, et al.
Publicado: (2008)

Novel human sex-typing strategies based on the autism candidate gene NLGN4X and its male-specific gametologue NLGN4Y
por: Maxeiner, Stephan, et al.
Publicado: (2019)

Calcium homeostasis in red blood cells of dialysis patients in dependence of erythropoietin treatment
por: Wang, Jue, et al.
Publicado: (2014)

The epidemiological relevance of the COVID-19-vaccinated population is decreasing after booster vaccination, as shown by incidence rate ratios
por: Bohnert, Jürgen A., et al.
Publicado: (2022)

Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
por: Wiening, Vanessa, et al.
Publicado: (2021)

Impact of COVID-19 in solid organ transplant recipients
por: Danziger-Isakov, Lara, et al.
Publicado: (2021)

Bioengineering of Anti‐Inflammatory Natural Products
por: Winand, Lea, et al.
Publicado: (2020)

Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination
por: Fousse, Mathias, et al.
Publicado: (2021)

Immunologic Effect of Bivalent mRNA Booster in Patients Undergoing Hemodialysis
por: Huth, Luca, et al.
Publicado: (2023)

Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine
por: Launay, Odile, et al.
Publicado: (2022)

Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab
por: Kos, Igor, et al.
Publicado: (2020)

Durability of Bivalent Boosters against Omicron Subvariants
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence
por: Lange, Christoph, et al.
Publicado: (2017)

Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans
por: Mayr, Florian B., et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Effectiveness of Bivalent Boosters against Severe Omicron Infection
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Aplasia Cutis and Ipsilateral Congenital Melanocytic Naevus: An Unusual Association
por: Gangopadhyay, Anusree, et al.
Publicado: (2013)

COVID-19 booster doses in pregnancy and global vaccine equity
por: Kalafat, Erkan, et al.
Publicado: (2022)

Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant
por: Zhao, Xin, et al.
Publicado: (2022)

WHO prequalified tocilizumab and vaccine boosters against COVID-19
por: Rahimi, Farid, et al.
Publicado: (2022)

Booster vaccinations protect shipboard personnel from COVID-19
por: Ryan, Margaret, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ummvq2ljc9osmh88oabe89vf8h